Orexo AB (publ)
OTC: ORXOY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Nikolaj Sørensen
- Employees
- 74
- Headquarters
- Uppsala, Sweden
- IPO year
- 2018
- Market cap
- $70.3M
- Website
- https://www.orexo.com
Loading ORXOY…
Loading profile data…Frequently asked questions about ORXOY
What does Orexo AB (publ) (ORXOY) do?
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and...
Where does ORXOY trade?
Orexo AB (publ) (ORXOY) trades on the Other OTC.
What sector is ORXOY in?
Orexo AB (publ) (ORXOY) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Orexo AB (publ)?
Nikolaj Sørensen is the chief executive officer of Orexo AB (publ) (ORXOY).
Where is Orexo AB (publ) headquartered?
Orexo AB (publ) is headquartered in Sweden.
Does ORXOY pay a dividend?
Orexo AB (publ) (ORXOY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ORXOY go public?
Orexo AB (publ) (ORXOY) completed its initial public offering in 2018.